Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Frederic Julien Fittler"'
Publikováno v:
Cells, Vol 9, Iss 9, p 2061 (2020)
Within the last decade, the introduction of checkpoint inhibitors proposed to boost the patients’ anti-tumor immune response has proven the efficacy of immunotherapeutic approaches for tumor therapy. Furthermore, especially in the context of the de
Externí odkaz:
https://doaj.org/article/1284f0fc6bfc45a28b29a9d15281fff5
Autor:
Monika, Bednarczyk, Carolina, Medina-Montano, Frederic Julien, Fittler, Henner, Stege, Meike, Roskamp, Michael, Kuske, Christian, Langer, Marco, Vahldieck, Evelyn, Montermann, Ingrid, Tubbe, Nadine, Röhrig, Andrzej, Dzionek, Stephan, Grabbe, Matthias, Bros
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2869, p 2869 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 6
International Journal of Molecular Sciences
Volume 22
Issue 6
The development of nanocarriers (NC) for biomedical applications has gained large interest due to their potential to co-deliver drugs in a cell-type-targeting manner. However, depending on their surface characteristics, NC accumulate serum factors, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3721038255e077cb662fc0f47162dd71
https://www.mdpi.com/1422-0067/22/6/2869
https://www.mdpi.com/1422-0067/22/6/2869
Publikováno v:
Cells
Cells, Vol 9, Iss 2061, p 2061 (2020)
Cells, Vol 9, Iss 2061, p 2061 (2020)
Within the last decade, the introduction of checkpoint inhibitors proposed to boost the patients’ anti-tumor immune response has proven the efficacy of immunotherapeutic approaches for tumor therapy. Furthermore, especially in the context of the de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d52a912ed0a6a178a7415ab262e5bf8e
https://pubmed.ncbi.nlm.nih.gov/32917034
https://pubmed.ncbi.nlm.nih.gov/32917034